Meabco A/S   Report issue

For profit Phase 1 Phase 2
Founded: Copenhagen Denmark (2001)

Organization Overview

First Clinical Trial
2009
NCT04298333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Meabco A/S